Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanezumab for pain associated with endometriosis
NCT00784693Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Dec 2008
- Primary completion
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tanezumab in endometriosis, sponsored by Pfizer. Started Dec 2008; status: terminated.
02
Drugs
tanezumab
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT00784693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00784693.